Evidence map›Paper›PMID 41940333›Full record

ReviewiScience2026

Idiopathic pulmonary fibrosis from a multiscale mechanobiology perspective: Mechanisms and future therapeutic prospects.

Tingting Xia, Xi Wang, Zhao Yang, Runze Zhao

Abstract readReview
In one paragraph

Review in iScience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Tingting XiaDepartment of Cell Biology, School of Basic Medical Sciences, Suzhou Medical College of Soochow University, Suzhou 215101, China.
Xi WangDepartment of Respiratory Medicine, Suzhou Hospital, Affiliated Hospital of Medical School, Nanjing University, Suzhou, Jiangsu 215153, China.
Zhao YangDepartment of Respiratory Medicine, Suzhou Hospital, Affiliated Hospital of Medical School, Nanjing University, Suzhou, Jiangsu 215153, China.
Runze ZhaoCenter of Translational Medicine, The Fourth Affiliated Hospital of Soochow University, Medical Center of Soochow University, Suzhou Dushu Lake Hospital, Suzhou, Jiangsu 215123, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Idiopathic pulmonary fibrosis (IPF) is a fatal interstitial lung disease that induces irreversible fibrosis and architectural remodeling. Traditional inflammation-based theories fall short in explaining its pathological processes, regional heterogeneity, and spatially biased lesion distribution. Recent studies have highlighted the critical role of biomechanical microenvironment, ranging from the molecular and cellular level to the whole-organ scale, in driving fibrotic progression. This review adopts a multiscale biomechanical perspective for understanding IPF pathogenesis, integrating molecular, cellular, tissue, and organ-level mechanisms. We summarize recent advances in IPF research from five key biomechanical perspectives: mechanotransduction, mechanical memory, extracellular matrix (ECM) stiffening, strain-induced fibroblast activation, and the spatial propagation of fibrosis. We further explore therapeutic strategies targeting mechanical signaling pathways and discuss the integration of machine learning and physics-informed neural networks (PINNs) for interpretable, physiology-constrained modeling. This review aims to provide a new mechanobiological perspective for understanding and intervening in IPF.

Indexed as

diseasemechanobiology

Identifiers

PMID41940333
PMCPMC13049428

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.